Market Overview

Concert Pharmaceuticals to Present at Upcoming Investor Conferences


Pharmaceuticals, Inc.
(NASDAQ:CNCE) today announced that it will
present a corporate overview at the following upcoming investor

  • The Wells Fargo Securities 2018 Healthcare Conference on September 5,
    2018 at 10:15 a.m. ET in Boston;
  • The H.C. Wainwright 20th Annual Global Investment Conference on
    September 6, 2018 at 10:00 a.m. ET in New York;
  • The Janney Montgomery Scott Healthcare Conference 2018 on September
    17, 2018 at 9:05 a.m. ET in New York; and
  • The 2018 Cantor Global Healthcare Conference on October 3, 2018 at
    10:20 a.m. ET in New York.

A live webcast of these presentations may be accessed in the Investors
section of the Company's website at
Please log on to the Concert website approximately 15 minutes prior to
the scheduled webcast to ensure adequate time for any software downloads
that may be required. A replay of the investor conference webcasts will
be available on Concert's website for two weeks following each

About Concert
is a clinical stage biopharmaceutical company
focused on applying its DCE
(deuterated chemical entity platform) to create novel
medicines designed to treat serious diseases and address unmet patient
needs. The Company's approach starts with previously studied compounds,
including approved drugs, in which deuterium substitution has the
potential to enhance clinical safety, tolerability or efficacy. Concert
has a broad
 of innovative medicines targeting autoimmune and
inflammatory diseases and central nervous systems (CNS) disorders. For
more information please visit
or follow us on Twitter at @ConcertPharma
or on LinkedIn.

Concert Pharmaceuticals Inc., the CoNCERT Pharmaceuticals Inc. logo and
DCE Platform are registered trademarks of Concert Pharmaceuticals, Inc.

View Comments and Join the Discussion!